The best of the North of England’s biomedical companies were honoured at the 2014 Biomedical Awards, hosted by Bionow at the BALTIC Centre for Contemporary Art, on Gateshead Quays (24 April 2014).
Sixteen companies battled it out in five award categories: Export, sponsored by CBSL; Outstanding Growth, sponsored by Sintons LLP; Innovation and Technology, sponsored by NETPark NET; Partnership/Collaboration of the Year, sponsored by Newcastle Biomedicine; and Promising Technologist of the Year, sponsored by Search Scientific, which is awarded to an exceptional individual who works for a biomedical company or research institution.
The winner of the Innovation and Technology Award was Newcastle-based Glythera, which develops next generation therapeutics through the application of its proprietary technologies, PermaLink™ and PermaCarb™. These technologies, used in the development of new or the re-positioning of current biotherapeutics, offer improved stability, bioavailability and efficiency in oncology and therapeutic applications. The company has focused the development of its PermaLink™ technology in the area of antibody drug conjugates (ADCs) and it has drawn significant interest from firms developing ADCs, resulting in national and international collaborations.
The 2014 Biomedical Awards are hosted by Bionow, the leading membership organisation for the biomedical and life sciences industry in the North of England. With over 210 subscribing members, Bionow’s membership offer focuses upon the specific needs of firms at their different stages of development, including dedicated business support programmes, shared procurement schemes with significant cost savings, exclusive insurance benefits, recruitment and training services, local and national events and access to a vibrant network of businesses.
The North of England is one of the UK and Europe’s largest biomedical regions; 20% of the UK’s biomedical companies, employment and turnover are in the North. Comprising of 925 life science and healthcare companies, the sector generates a turnover of £10.9bn and employs over 38,000 people. The area is home to the N8 Research Partnership, and boasts world-leading resources in terms of investment, scientific expertise, academic research, science graduates, NHS hospitals and state of the art manufacturing facilities.
Please find more information at www.thejournal.co.uk